Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.

× No keyword cloud information.

51 in total

1. Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors: K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal: Proc Natl Acad Sci U S A Date: 1989-01 Impact factor: 11.205

Review 2. Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors: T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal: Neuroscience Date: 2008-07-12 Impact factor: 3.590

3. Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. A model for the in vitro study of increased vasopermeability.

Authors: J J Killackey; M G Johnston; H Z Movat
Journal: Am J Pathol Date: 1986-01 Impact factor: 4.307

4. Reduced expression of C5a receptors on neutrophils from cord blood.

Authors: M Nybo; O Sørensen; R Leslie; P Wang
Journal: Arch Dis Child Fetal Neonatal Ed Date: 1998-03 Impact factor: 5.747

5. Treatment with isoproterenol of bupivacaine toxicity.

Authors: P Lacombe; G Blaise; F Plante; C Hollmann
Journal: Can J Anaesth Date: 1990-05 Impact factor: 5.063

6. Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations.

Authors: D G Nettesheim; R P Edalji; K W Mollison; J Greer; E R Zuiderweg
Journal: Proc Natl Acad Sci U S A Date: 1988-07 Impact factor: 11.205

Review 7. Structure and function of the anaphylatoxins.

Authors: T E Hugli
Journal: Springer Semin Immunopathol Date: 1984

8. Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.

Authors: Edward L Morgan; Brandon N Morgan; Elisabeth A Stein; Elizabeth L Vitrs; Marilyn L Thoman; Sam D Sanderson; Joy A Phillips
Journal: Vaccine Date: 2009-10-15 Impact factor: 3.641

9. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.

Authors: D F Carney; T E Hugli
Journal: Protein Sci Date: 1993-09 Impact factor: 6.725

10. Isolation of three separate anaphylatoxins from complement-activated human serum.

Authors: T E Hugli; C Gerard; M Kawahara; M E Scheetz; R Barton; S Briggs; G Koppel; S Russell
Journal: Mol Cell Biochem Date: 1981-12-04 Impact factor: 3.396